Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis

Details for Australian Patent Application No. 2006320480 (hide)

Owner Bayer HealthCare LLC

Inventors Kluender, Harold; Newcom, Jason; Allegue, Kristen; Zhang, Zhonghua; Chandler, Brent; Liu, Zheng; Parcella, Kyle; Wang, Yamin; Magnuson, Steven; Hong, Zhenqiu; Dixon, Julie; Phillips, Barton; Li, Tindy

Agent Davies Collison Cave

Pub. Number AU-B-2006320480

PCT Pub. Number WO2007/064883

Priority 60/742,151 02.12.05 US

Filing date 30 November 2006

Wipo publication date 7 June 2007

Acceptance publication date 10 November 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/064883 Priority application(s): WO2007/064883

10 November 2011 Application Accepted

  Published as AU-B-2006320480

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006320482-Oral care compositions, methods, devices and systems

2006320479-Treatment of conditions involving demyelination